The two enantiomers of acetyl cycloserine 8, the immediate precursors of the chiral forms of cycloserine 1, were prepared in enantiomeric excess higher than 98\% by means of lipase-catalyzed hydrolysis of 3-benzyloxy-4-hydroxy-DELTA2-isoxazoline butyrate (+/-)-5. Among the five lipases tested, lipase from Chromobacterium viscosum was by far the most selective catalyst. Since the enantiomeric ratio (E) of the reaction was higher than 100, the hydrolysis spontaneously stopped at 50\% conversion to yield (R)-3-benzyloxy-4-hydroxy-DELTA2-isoxazoline {[(R)-(+)-4] and (S)-3-benzyloxy-4-hydroxy-DELTA2-isoxazoline butyrate [(S)-(-)-5] in almost enantiomerically pure form. Intermediates (R)-(+)-4 and (S)-(-)-5 were transformed into the enantiomers of acetyl cycloserine through a four step sequence. This strategy constitutes a valid alternative to the previously reported procedures.}

CHEMOENZYMATIC SYNTHESIS OF ACETYL (R)-(+)-CYCLOSERINE AND (S)-(-)-CYCLOSERINE / M. De Amici, C. De Micheli, F. Cateni, G. Carrea, G. Ottolina. - In: TETRAHEDRON-ASYMMETRY. - ISSN 0957-4166. - 4:5(1993), pp. 1073-1080. [10.1016/S0957-4166(00)80156-1]

CHEMOENZYMATIC SYNTHESIS OF ACETYL (R)-(+)-CYCLOSERINE AND (S)-(-)-CYCLOSERINE

M. De Amici;C. De Micheli;
1993

Abstract

The two enantiomers of acetyl cycloserine 8, the immediate precursors of the chiral forms of cycloserine 1, were prepared in enantiomeric excess higher than 98\% by means of lipase-catalyzed hydrolysis of 3-benzyloxy-4-hydroxy-DELTA2-isoxazoline butyrate (+/-)-5. Among the five lipases tested, lipase from Chromobacterium viscosum was by far the most selective catalyst. Since the enantiomeric ratio (E) of the reaction was higher than 100, the hydrolysis spontaneously stopped at 50\% conversion to yield (R)-3-benzyloxy-4-hydroxy-DELTA2-isoxazoline {[(R)-(+)-4] and (S)-3-benzyloxy-4-hydroxy-DELTA2-isoxazoline butyrate [(S)-(-)-5] in almost enantiomerically pure form. Intermediates (R)-(+)-4 and (S)-(-)-5 were transformed into the enantiomers of acetyl cycloserine through a four step sequence. This strategy constitutes a valid alternative to the previously reported procedures.}
Settore CHIM/08 - Chimica Farmaceutica
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/184422
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 9
  • ???jsp.display-item.citation.isi??? 11
social impact